Tenofovir Alafenamide
1 NDC across 1 manufacturer|0 Generic,1 Brand
Tenofovir Alafenamide is used to treat acquired immunodeficiency syndrome and chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $199 million on Tenofovir Alafenamide across 129,000 claims for 15,000 beneficiaries.
Tenofovir Alafenamide is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $51.98 to $51.98 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$51.98 – $51.98
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TENOFOVIR ALAFENAMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VEMLIDY 25 MG TABLET | $51.9830 per EA | +0.01% |
Frequently Asked Questions
What is Tenofovir Alafenamide used to treat?
Tenofovir Alafenamide is used to treat acquired immunodeficiency syndrome and chronic hepatitis b, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Tenofovir Alafenamide?
In 2024, Medicare Part D spent $199 million on Tenofovir Alafenamide across 129,000 claims for 15,000 beneficiaries.
How many Tenofovir Alafenamide products are on the market?
The Tenofovir Alafenamide drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Tenofovir Alafenamide?
NADAC reference prices for Tenofovir Alafenamide range from $51.9830 to $51.9830 per EA.
Which manufacturers make Tenofovir Alafenamide?
1 manufacturer lists Tenofovir Alafenamide in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1).
How has the price of Tenofovir Alafenamide changed recently?
Over the past 7 days, 2 Tenofovir Alafenamide NDCs rose and 0 fell, with a market-wide average change of +0.0%.